ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
Dow Jones
41.938,45
-1,63%
Euro vs US Dollar
1,02555
0,00%
Bitcoin
94.239,23
-0,49%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. IDEXX Laboratories Inc (IDXX)

  7. IDEXX Laboratories Inc (IDXX) News

IDXX

IDEXX Laboratories (IDXX)

IDEXX Laboratories Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:IDXX
DatumZeitQuelleÜberschriftSymbolFirma
19/12/202416h09GlobeNewswire Inc.SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXXNASDAQ:IDXXIDEXX Laboratories Inc
12/12/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDXXIDEXX Laboratories Inc
09/12/202413h32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDXXIDEXX Laboratories Inc
09/12/202413h30Business WireIDEXX Laboratories Announces Increase in Share Repurchase Program AuthorizationNASDAQ:IDXXIDEXX Laboratories Inc
29/11/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
27/11/202422h36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
21/11/202413h32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDXXIDEXX Laboratories Inc
21/11/202413h30Business WireIDEXX Announces CFO TransitionNASDAQ:IDXXIDEXX Laboratories Inc
12/11/202413h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDXXIDEXX Laboratories Inc
06/11/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDXXIDEXX Laboratories Inc
31/10/202421h14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IDXXIDEXX Laboratories Inc
31/10/202418h23Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:IDXXIDEXX Laboratories Inc
31/10/202418h15Business WireCORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter ResultsNASDAQ:IDXXIDEXX Laboratories Inc
31/10/202411h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDXXIDEXX Laboratories Inc
31/10/202411h30Business WireIDEXX Laboratories Announces Third Quarter ResultsNASDAQ:IDXXIDEXX Laboratories Inc
30/09/202420h00Business WireIDEXX Laboratories to Release 2024 Third Quarter Financial ResultsNASDAQ:IDXXIDEXX Laboratories Inc
09/09/202422h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
09/09/202422h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
06/09/202422h36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
05/09/202402h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
05/09/202402h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
21/08/202422h15Business WireIDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:IDXXIDEXX Laboratories Inc
07/08/202423h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
07/08/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDXXIDEXX Laboratories Inc
06/08/202412h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDXXIDEXX Laboratories Inc
06/08/202412h30Business WireIDEXX Laboratories Announces Second Quarter ResultsNASDAQ:IDXXIDEXX Laboratories Inc
30/07/202423h53Business WireIDEXX Laboratories Announces Time Change for 2024 Second Quarter Financial Results Conference CallNASDAQ:IDXXIDEXX Laboratories Inc
30/07/202413h00PR Newswire (US)IDEXX Releases 2023 Corporate Responsibility Report, Highlighting Progress Against Its GoalsNASDAQ:IDXXIDEXX Laboratories Inc
24/06/202417h00Business WireIDEXX Laboratories to Release 2024 Second Quarter Financial ResultsNASDAQ:IDXXIDEXX Laboratories Inc
04/06/202413h00PR Newswire (Canada)IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing PancreatitisNASDAQ:IDXXIDEXX Laboratories Inc
 Showing the most relevant articles for your search:NASDAQ:IDXX

Kürzlich von Ihnen besucht

USOTC
DTEGY
Deutsche Telekom (QX)
TG
MBG
MercedesBenz
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
GOOGL
Alphabet
AMEX
XLE
Energy Select Sector SPDR
TG
ALV
Allianz
AMEX
XLV
Health Care Select Sector
COIN
BTCUSD
Bitcoin
NYSE
XOM
Exxon Mobil
DBI
MDAX
MDAX
USOTC
RHHBY
Roche (QX)
CCOM
SILVER
SILVER
AMEX
XLF
Financial Select Sector
TG
LHA
Deutsche Lufthansa
TG
BAYN
Bayer
COIN
SOLUSD
Solana
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten